About
Tubulis Technologies develops tubulin-based antibody-drug conjugates for targeted cancer therapies using deep biological engineering approaches.
Explore Tubulis Technologies's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.